Author Correction: A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite (Nature Communications, (2020), 11, 1, (6094), 10.1038/s41467-020-19981-6)

Laura Oana Albulescu, Chunfang Xie, Stuart Ainsworth, Jaffer Alsolaiss, Edouard Crittenden, Charlotte A. Dawson, Rowan Softley, Keirah E. Bartlett, Robert A. Harrison, Jeroen Kool, Nicholas R. Casewell*

*Corresponding author for this work

Research output: Contribution to JournalComment / Letter to the editorAcademic

Abstract

The original version of this articles contained an error in Fig. 4. The graphs in panel B report the neutralization of SVSP venom by decreasing concentrations of the inhibitor nafamostat, from 150 μm to 150 nm, but the lowest concentration on the X-axis was incorrectly reported as 150 μm. This error has now been corrected on the PDF and HTML version of the article.

Original languageEnglish
Article number4027
Pages (from-to)1
Number of pages1
JournalNature Communications
Volume12
Issue number1
Early online date24 Jun 2021
DOIs
Publication statusPublished - Dec 2021

Bibliographical note

Publisher Copyright:
© The Author(s) 2021

Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.

Correction to:Nature Communicationshttps://doi.org/10.1038/s41467-020-19981-6, published online 15 December 2020.

Fingerprint

Dive into the research topics of 'Author Correction: A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite (Nature Communications, (2020), 11, 1, (6094), 10.1038/s41467-020-19981-6)'. Together they form a unique fingerprint.

Cite this